Is Editas Medicine, Inc. (EDIT) a Buy, Sell, or Hold?
Editas Medicine, Inc.
NASDAQ:EDIT
$3.16 USD
$0 (0.0%)
- Volume
- 1.84M
- Average Volume
- 2.52M
- Market Capitalization
- $309.36M
- P/E Ratio
- -2.57
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $4.54
- Year Low
- $1.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.22
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
3
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
14
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 42529
EDIT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
EDIT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Connaughton Bernadette | director | 2026-06-17 | A-Award | 2.55 | 2026-06-22 |
| Hopfield Jessica | director | 2026-06-17 | A-Award | 2.55 | 2026-06-22 |
| Hirsch Andrew | director | 2026-06-17 | A-Award | 2.55 | 2026-06-22 |
| Scadden David | director | 2026-06-17 | A-Award | 2.55 | 2026-06-22 |
| Levy Elliott M. | director | 2026-06-17 | A-Award | 2.55 | 2026-06-22 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2026-06-03 | S-Sale | 2.701 | 2026-06-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2026-06-03 | S-Sale | 2.7011 | 2026-06-05 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2026-06-03 | S-Sale | 2.7011 | 2026-06-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2026-03-12 | A-Award | 2.54 | 2026-03-16 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2026-03-12 | A-Award | 2.54 | 2026-03-16 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2026-03-12 | A-Award | 2.54 | 2026-03-16 |
| O'Neill Gilmore Neil | director, officer: CEO | 2026-03-03 | S-Sale | 2.0197 | 2026-03-04 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2026-03-03 | S-Sale | 2.02 | 2026-03-04 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2026-03-03 | S-Sale | 2.0196 | 2026-03-04 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2025-12-03 | S-Sale | 2.1531 | 2025-12-04 |
| O'Neill Gilmore Neil | director, officer: CEO | 2025-12-03 | S-Sale | 2.1531 | 2025-12-04 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-12-03 | S-Sale | 2.1531 | 2025-12-04 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2025-09-03 | S-Sale | 2.5961 | 2025-09-04 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-09-03 | S-Sale | 2.5961 | 2025-09-04 |
| O'Neill Gilmore Neil | director, officer: CEO | 2025-09-03 | S-Sale | 2.5961 | 2025-09-04 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-08-07 | S-Sale | 2.58 | 2025-08-08 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2025-07-31 | S-Sale | 2.4911 | 2025-08-04 |
| Hopfield Jessica | director | 2025-06-06 | A-Award | 1.91 | 2025-06-10 |
| Scadden David | director | 2025-06-06 | A-Award | 1.91 | 2025-06-10 |
| Levy Elliott M. | director | 2025-06-06 | A-Award | 1.91 | 2025-06-10 |
| Connaughton Bernadette | director | 2025-06-06 | A-Award | 1.91 | 2025-06-10 |
| Hirsch Andrew | director | 2025-06-06 | A-Award | 1.91 | 2025-06-10 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-06-03 | S-Sale | 1.724 | 2025-06-04 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2025-06-03 | S-Sale | 1.7243 | 2025-06-04 |
| O'Neill Gilmore Neil | director, officer: CEO | 2025-06-03 | S-Sale | 1.7243 | 2025-06-04 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-04-08 | A-Award | 0.98 | 2025-04-08 |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-03-28 | 0 | 2025-04-08 | |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-03-28 | 8.72 | 2025-04-08 | |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-03-28 | 9.92 | 2025-04-08 | |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-03-28 | 1.72 | 2025-04-08 | |
| Parison Amy | officer: SVP, Chief Financial Officer | 2025-03-28 | 15.83 | 2025-04-08 | |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2025-03-08 | A-Award | 1.72 | 2025-03-27 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2025-03-08 | A-Award | 1.72 | 2025-03-27 |
| O'Neill Gilmore Neil | director, officer: CEO | 2025-03-08 | A-Award | 1.72 | 2025-03-27 |
| O'Neill Gilmore Neil | director, officer: CEO | 2025-03-08 | A-Award | 1.72 | 2025-03-27 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2025-03-08 | A-Award | 1.72 | 2025-03-27 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2025-03-08 | A-Award | 1.72 | 2025-03-27 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2025-03-04 | S-Sale | 1.7108 | 2025-03-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2025-03-04 | S-Sale | 1.7107 | 2025-03-05 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2025-03-04 | S-Sale | 1.7107 | 2025-03-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-12-03 | S-Sale | 2.0774 | 2024-12-05 |
| Mei Baisong | officer: EVP, CHIEF MEDICAL OFFICER | 2024-12-03 | S-Sale | 2.0772 | 2024-12-05 |
| Mei Baisong | officer: EVP, CHIEF MEDICAL OFFICER | 2024-09-04 | S-Sale | 3.4247 | 2024-09-06 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-09-04 | S-Sale | 3.4247 | 2024-09-06 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2024-07-25 | S-Sale | 5.4156 | 2024-07-26 |
| Mei Baisong | officer: EVP, CHIEF MEDICAL OFFICER | 2024-07-19 | S-Sale | 5.2056 | 2024-07-22 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-06-04 | S-Sale | 5.4956 | 2024-06-06 |
| Mei Baisong | officer: EVP, CHIEF MEDICAL OFFICER | 2024-06-04 | S-Sale | 5.4956 | 2024-06-06 |
| Scadden David | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Hopfield Jessica | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Chatterjee Meeta | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Hirsch Andrew | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Reeve Emma | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Levy Elliott M. | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Connaughton Bernadette | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Vaishnaw Akshay | director | 2024-05-30 | A-Award | 5.17 | 2024-06-03 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2024-05-20 | S-Sale | 5.6142 | 2024-05-22 |
| Hopfield Jessica | director | 2024-05-13 | P-Purchase | 5.6415 | 2024-05-14 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2024-03-02 | A-Award | 10.53 | 2024-03-05 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2024-03-02 | A-Award | 10.53 | 2024-03-05 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-03-02 | A-Award | 10.53 | 2024-03-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-03-05 | S-Sale | 9.4172 | 2024-03-05 |
| O'Neill Gilmore Neil | director, officer: CEO | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| Mei Baisong | officer: SVP, CHIEF MEDICAL OFFICER | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| Mei Baisong | officer: SVP, CHIEF MEDICAL OFFICER | 2024-03-02 | A-Award | 10.53 | 2024-03-05 |
| Mei Baisong | officer: SVP, CHIEF MEDICAL OFFICER | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| Mei Baisong | officer: SVP, CHIEF MEDICAL OFFICER | 2024-03-04 | S-Sale | 9.4173 | 2024-03-05 |
| Mei Baisong | officer: SVP, CHIEF MEDICAL OFFICER | 2024-03-02 | A-Award | 0 | 2024-03-05 |
| Eaton Bruce | officer: EVP, CBO AND CTO | 2023-12-05 | S-Sale | 10.8972 | 2023-12-07 |
| Eaton Bruce | officer: EVP, CBO AND CTO | 2023-11-14 | S-Sale | 8.2096 | 2023-11-16 |
| Eaton Bruce | officer: EVP, CBO AND CTO | 2023-11-07 | S-Sale | 8.4 | 2023-11-09 |
| Eaton Bruce | officer: EVP, CBO AND CTO | 2023-09-06 | S-Sale | 8.82 | 2023-09-07 |
| Eaton Bruce | officer: EVP, CBO AND CTO | 2023-08-11 | S-Sale | 8.5935 | 2023-08-15 |
| Eaton Bruce | officer: EVP, CBO AND CTO | 2023-08-08 | S-Sale | 8.39 | 2023-08-10 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2023-07-24 | A-Award | 8.66 | 2023-07-25 |
| Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | 2023-07-24 | A-Award | 0 | 2023-07-25 |
| Burkly Linda | 2023-07-24 | 0 | 2023-07-25 | ||
| Mei Baisong | officer: SVP, CHIEF MEDICAL OFFICER | 2023-07-19 | S-Sale | 8.8 | 2023-07-21 |
| O'Neill Gilmore Neil | director, officer: CEO | 2023-06-05 | S-Sale | 9.5032 | 2023-06-07 |
| Eaton Bruce | officer: EVP, CBO AND CTO | 2023-06-05 | S-Sale | 9.503 | 2023-06-07 |
| Hopfield Jessica | director | 2023-06-01 | A-Award | 9.55 | 2023-06-05 |
| Connaughton Bernadette | director | 2023-06-01 | A-Award | 9.55 | 2023-06-05 |
| Reeve Emma | director | 2023-06-01 | A-Award | 9.55 | 2023-06-05 |
| Vaishnaw Akshay | director | 2023-06-01 | A-Award | 9.55 | 2023-06-05 |
| Hirsch Andrew | director | 2023-06-01 | A-Award | 9.55 | 2023-06-05 |
| Scadden David | director | 2023-06-01 | A-Award | 9.55 | 2023-06-05 |
| Chatterjee Meeta | director | 2023-06-01 | A-Award | 9.55 | 2023-06-05 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2023-05-17 | A-Award | 9.61 | 2023-05-18 |
| Lucera Erick | officer: EVP, CHIEF FINANCIAL OFFICER | 2023-05-17 | A-Award | 0 | 2023-05-18 |